Press releases

25 Nov 2019

Efforts to register new hepatitis C treatment in Malaysia receive support from Pharmaniaga

Press releases

25 Nov 2019

DNDi receives $29 million to fast-track the development of drugs to help eliminate sleeping sickness and river blindness

Press releases

20 Nov 2019

Study shows that African eye worm threatens elimination of river blindness

Press releases

30 Oct 2019

Not-for-profit research and development can address deadly market failure for neglected patients, paper shows

Press releases

18 Oct 2019

The French development agency AFD renews its support for the Drugs for Neglected Diseases initiative (DNDi) in researching and developing treatments for neglected tropical diseases

Press releases

26 Sep 2019

Lack of awareness of Chagas disease in the US leading to unnecessary deaths in vulnerable immigrant communities

Press releases

15 Sep 2019

La cuvée 2018 de la ‘Vigne des Nations’ de la République et canton de Genève dédiée à DNDi en reconnaissance de son travail auprès des patients les plus négligés

Press releases

22 Jul 2019

Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows

Press releases

17 Jul 2019

Nationwide hepatitis C screening campaign initiated by the Malaysian Ministry of Health

Press releases

20 Jun 2019

Chagas Access Programme achieves an increase of 1300% in the number of people screened

Press releases

24 May 2019

Following 110 years of neglect, an official day for Chagas disease is declared

Press releases

16 Apr 2019

DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases

Press releases

11 Apr 2019

Chagas disease: the time is now to end 110 years of neglect

Press releases

2 Apr 2019

GARDP set up as independent legal entity

Press releases

14 Mar 2019

Study shows dramatically shorter treatment for Chagas disease could be just as effective, and significantly safer

Press releases

5 Feb 2019

Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis